| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919114 | Radiotherapy and Oncology | 2013 | 6 Pages |
Abstract
IMAT for N1 PCa offers good clinical outcome with moderate toxicity. Patients with cN1 disease have poorer outcome.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Valérie Fonteyne, Nicolaas Lumen, Piet Ost, Charles Van Praet, Katrien Vandecasteele, Werner De Gersem Ir, Geert Villeirs, Wilfried De Neve, Karel Decaestecker, Gert De Meerleer,